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for physicians to use available knowledge and judgment
to provide the best possible care to their patients. In return,
physicians hope to earn the trust and respect of their
patients and community. Physicians have the historical
opportunity of autonomy in their practice and with that
comes the responsibility and privilege of self-regulation
(1,2). Unfortunately, as health care costs continue to spiral
upward, concerns about the overuse and misuse of costly
procedures have been amplified. In response, the commu-
nities at large, and specifically payers, have implemented
volume- and cost-control mechanisms. One approach is to
require “pre-authorization” for services—an activity gener-
ally felt by physicians and their office staff to be onerous,
expensive to operationalize, intrusive on the physician–
patient relationship, and lacking educational feedback to
improve quality of care. Another questionable mechanism is
to arbitrarily decrease payments for services. Paradoxically,
this has potential to increase the volume of services, or even
worse, result in underuse of services, which may be essential
for improved outcomes in a particular patient. Amid this
turmoil, many have asked, “Is there not a better way?”
In response to these growing concerns and to develop a
culture in which we, as professionals, are better stewards of
the privilege of self-regulation, the American College of
Cardiology in collaboration with many other professional
organizations developed appropriate use criteria (AUC) for
cardiovascular imaging modalities and recently coronary
revascularization (3). The methodology for this process has
been well described (4,5).
In this issue of the Journal, Chan et al. (6) reported survey
ata examining the AUC for coronary revascularization.
efore publication of the AUC, they conducted an elec-
ronic survey of 85 practicing cardiologists who were asked
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described in the coronary revascularization AUC. Overall,
there was agreement in the median appropriateness rating
(appropriate, uncertain, or inappropriate) in 84% of the
indications reviewed, 94% (34 of 36) for appropriate indi-
cations, 73% (16 of 22) for uncertain indications, and 70%
(7 of 10) for inappropriate indications. The study also
reported the “nonagreement” within the surveyed cardiolo-
gists. This was defined as 25% of the individual ratings
being scored such that they were in a different appropriate-
ness classification. Specific variation between the ratings of
the original AUC Technical Panel and physicians in their
survey were identified. Chan et al. (6) should be com-
mended for moving the dialogue forward and further
evaluating how AUC may be perceived by the physician
community.
Although their study is interesting, it is important to
identify important differences between their survey and the
rigorous AUC process so that concerns about measurement,
reporting, and quality assessment can be addressed. Com-
pared with that of the AUC Technical Panel, the compo-
sition of the physicians surveyed was different. The AUC
process requires that fewer than 50% of the physicians
perform the procedure under question, and that was
achieved in the composition of the technical panel with 4
interventional cardiologists and 4 cardiothoracic surgeons
among the 17 panel members. In contrast, the physician
survey group had a majority of invasive cardiologists and
surprisingly no cardiac surgeons. The survey also lacked an
important step in the modified RAND methodology. The
initial ratings in the formal AUC process are performed
independently by each member of the technical panel.
Then, in contrast to the survey, there is a face-to-face
meeting of the technical panel in which the clinical scenar-
ios and especially those with considerable “nonagreement”
among the initial ratings are discussed. The goal of the
face-to-face meeting is neither consensus building nor to
force “groupthink” but rather to encourage that decisions of
each technical panel member are based on the best available
and relevant published reports rather than personal opinion
or bias. After returning home from the meeting, each
technical panel member again independently rates each of
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mated 20 to 25 h reviewing the evidence base and rating the
indications rather than simply completing a 1-time elec-
tronic survey. Results of the first round of voting are
typically more diverse than those of the second and final
vote. Although critics of this process may claim this reflects
pressure to conform to the desires of the group, second
round voting remains independent and blinded.
As cited in the AUC online appendix, there is substantial
evidence regarding the benefits (health status and/or sur-
vival) of medical therapy, coronary intervention, and bypass
surgery across the range of clinical scenarios evaluated.
Equally important is evidence demonstrating a lack of
benefit for the majority of indications rated as inappropriate.
Patients and even some physicians have difficulty reconcil-
ing what they hope are benefits of coronary intervention on
survival and myocardial infarction with the proven benefits
on symptom relief in patients without severe disease (7–9).
This may explain, in part, the “nonagreement” between the
AUC and surveyed physicians regarding inappropriate rat-
ings. Indeed, 4 of the 10 inappropriate scenarios chosen by
Chan et al. (6) for their survey were for asymptomatic
patients without moderate or severe anatomic risk. Evidence
suggests that these patients would have difficulty deriving
any benefit because they have no symptoms to relieve and do
not have complex disease. Viewed in the context of the
differences between the survey and the actual AUC process,
the overall 84% agreement is, in our opinion, quite good.
One can only speculate that the agreement may have been
higher had the survey been conducted on all of the clinical
scenarios rather than just one-third and with the same
published reports review and rigor as the RAND method-
ology dictates.
Some in the cardiovascular community are concerned
that the AUC process, public reporting, and inappropri-
ate ratings could prevent patients from receiving cutting-
edge therapies based on the latest studies. Although new
evidence is constantly being developed, it is rare that one
study is definitive enough to change clinical practice.
Often subsequent studies or those with longer follow-up
have results that contradict or temper the initial report.
In fact, a lack of definitive studies or the presence of only
small hypothesis-generating subgroup analyses is com-
mon among indications rated as inappropriate. It is also
critically important to understand and not distort the
meaning of inappropriate rating categories. It was never
expected that any physician or facility would have a zero
rate of inappropriate procedures. There may be unique
clinical and patient-specific reasons that justify a proce-
dure rated in this category. However, when the frequency
of these ratings becomes higher than the norm, we should
have the courage to ask why and consider additional
documentation to justify the procedure. Although this
sounds onerous, is it not better for us to impose these
controls on ourselves than what is done currently by
payers to control costs and procedures?Many clinicians acknowledge that inappropriate pro-
cedures are occurring, but no one will admit that they
have personally done one. Therein is the perfect descrip-
tion of the situation we now face. Our profession has the
privilege of self-regulation, and this is our struggle.
Failure to accept this responsibility will only accelerate
regulation by those whose motives may be different and
who are not at the bedside with the patient. Is there not
a better way?
How can benchmarking based on AUC be rationally
implemented and improved without impeding doctor–
patient relationships and innovation? The AUC must re-
main current with the evidence. In the 5 years since the first
AUC was published, 3 of the 5 AUC have already been
updated, and an update of the coronary revascularization
AUC is underway just 20 months after its publication.
Equally important is continued feedback regarding imple-
mentation of the AUC. Differences between practice pat-
terns and the AUC must be identified. Version 4.0 of the
CathPCI (Catheterization/Percutaneous Coronary Inter-
vention) Registry was designed to collect the necessary
information to benchmark participants based on the coro-
nary revascularization AUC. Data repositories like the
National Cardiovascular Data Registry will highlight areas
for which differences between real-life practice and the
AUC may require modifications in clinical practice, the
AUC, or both. Moreover, such comparisons will identify
when new research is needed to clarify the benefits and risks
for a specific patient population. Benchmarking of facility-
and potentially physician-specific patient selection through
the National Cardiovascular Data Registry can guide better
understanding of practice patterns and patient mix. Evalu-
ation of such data can highlight not only potential areas of
overuse but also underuse (10). Such evaluations are the best
way to dispel misconceptions and misinformation such as
the assertion that more than 50% of all PCIs in the U.S. are
unnecessary, when based on prior studies of guidelines
adherence, only 8% do not match current recommendations
(11,12). However, it is critical for everyone and especially
payers to understand that the AUC were never intended to
be the final answer in determining payment for procedures.
Used for their intended purpose, the AUC can improve
patient care and intelligently prevent misuse of procedures
while reducing costs. Finally, and potentially most impor-
tantly, involvement from the cardiovascular community in
benchmarking will undoubtedly refine their understanding
about the benefits and risk of procedures and in turn impact
acceptance of the current AUC and help craft future updates
of the AUC.
It should be clear that the current process is not “group
think” or the will of the masses but rather a thoughtful
evaluation of available evidence-based data with repre-
sentation from diverse stakeholders. To have meaningful
traction with our colleagues, payers, and most impor-
tantly our patients, we must continue to provide a
transparent and impartial evaluation of our practices
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helps us reflect on the value of care we provide to
patients. With this continued work, we hope to keep the
privilege of self-regulation and most importantly the trust
of our community and patients. If cardiovascular special-
ists do not attempt to define and measure appropriate-
ness, we may lose the last opportunity for thoughtful and
meaningful self-regulation.
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